The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility

被引:102
作者
Kjoller, L [1 ]
机构
[1] Rigshosp, Finsen Lab, DK-2100 Copenhagen O, Denmark
关键词
adhesion; integrins; plasminogen activation; proteases; signal transduction; vitronectin;
D O I
10.1515/BC.2002.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell migration is a complex process requiring tight control of several mechanisms including dynamic reorganization of the actin cytoskeleton and adhesion to the extracellular matrix. The GPI-anchored urokinase plasminogen activator receptor (uPAR) has an important role in the regulation of cell motility in many cell types. This is partly due to the localization of proteolytic activity on the cell surface by binding of the serine protease uPA. Results accumulated over the last decade suggest that uPAR is also involved in motility control through other mechanisms. These include induction of signal transduction events after ligation with uPA, binding to the extracellular matrix molecule vitronectin (VN), and association with integrins and other transmembrane partners. In this review these mechanisms will be discussed with a special emphasis on how the GPI-linked receptor transmits signals to the intracellular milieu and how uPAR participates in the regulation of actin cytoskeleton reorganization and cell adhesion during cell migration.
引用
收藏
页码:5 / 19
页数:15
相关论文
共 151 条
[1]  
Adam L, 2001, CANCER RES, V61, P81
[2]   Urokinase receptor and fibronectin regulate the ERKMAPK to p38MAPK activity ratios that determine carcinoma cell proliferation or dormancy in vivo [J].
Aguirre-Ghiso, JA ;
Liu, D ;
Mignatti, A ;
Kovalski, K ;
Ossowski, L .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (04) :863-879
[3]   Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways [J].
Anand-Apte, B ;
Zetter, BR ;
Viswanathan, A ;
Qiu, RG ;
Chen, J ;
Ruggieri, R ;
Symons, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30688-30692
[4]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[5]  
2-Z
[6]   PRODUCTION OF 2ND MESSENGERS FOLLOWING CHEMOTACTIC AND MITOGENIC UROKINASE-RECEPTOR INTERACTION IN HUMAN FIBROBLASTS AND MOUSE FIBROBLASTS TRANSFECTED WITH HUMAN UROKINASE RECEPTOR [J].
ANICHINI, E ;
FIBBI, G ;
PUCCI, M ;
CALDINI, R ;
CHEVANNE, M ;
DELROSSO, M .
EXPERIMENTAL CELL RESEARCH, 1994, 213 (02) :438-448
[7]   THE VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR MEDIATES THE CELLULAR CATABOLISM OF LIPOPROTEIN-LIPASE AND UROKINASE-PLASMINOGEN ACTIVATOR INHIBITOR TYPE-I COMPLEXES [J].
ARGRAVES, KM ;
BATTEY, FD ;
MACCALMAN, CD ;
MCCRAE, KR ;
GAFVELS, M ;
KOZARSKY, KF ;
CHAPPELL, DA ;
STRAUSS, JF ;
STRICKLAND, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26550-26557
[8]   Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK [J].
Barberis, L ;
Wary, KK ;
Fiucci, G ;
Liu, F ;
Hirsch, E ;
Brancaccio, M ;
Altruda, F ;
Tarone, G ;
Giancotti, FG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36532-36540
[9]   The urokinase receptor [J].
Behrendt, N ;
Stephens, RW .
FIBRINOLYSIS & PROTEOLYSIS, 1998, 12 (04) :191-204
[10]   A urokinase receptor-associated protein with specific collagen binding properties [J].
Behrendt, N ;
Jensen, ON ;
Engelholm, LH ;
Mortz, E ;
Mann, M ;
Dano, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :1993-2002